Cleveland BioLabs narrows loss in third quarter
Buffalo News
Cleveland BioLabs narrowed its third quarter loss by 24 percent as the Buffalo drug development company cut its operating expenses by almost 14 percent. Cleveland BioLabs said it lost $3.1 million, or 31 cents per share, compared with a loss of $4.1 ...and more »
Buffalo News
Cleveland BioLabs narrowed its third quarter loss by 24 percent as the Buffalo drug development company cut its operating expenses by almost 14 percent. Cleveland BioLabs said it lost $3.1 million, or 31 cents per share, compared with a loss of $4.1 ...and more »